1117. Deputy Ken O'Flynn asked the Minister for Health when the proposed national scheme for safe disposal of unused medicines will be introduced; what funding has been allocated; whether it will involve community pharmacies; and whether it will operate nationally. [38769/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
1,428 questions match, newest first.
1118. Deputy Ken O'Flynn asked the Minister for Health whether the HSE reimburses medicines which are dispensed but never collected by patients; what safeguards exist to prevent unnecessary reimbursement; and whether data on uncollected medicines is centrally collected. [38770/26]
1119. Deputy Ken O'Flynn asked the Minister for Health whether medication reviews for patients on multiple prescriptions are being used systematically to reduce over-prescribing, duplication, and avoidable waste; and what targets or KPIs apply. [38771/26]
1120. Deputy Ken O'Flynn asked the Minister for Health whether his Department has assessed potential savings from reducing medicines waste by 10%, 20% or 30%; and whether such savings have been modelled for reinvestment in frontline pharmacy or prescribing services. [38772/26]
1121. Deputy Conor D. McGuinness asked the Minister for Health the number of WTE qualified medical dosimetrists posts filled at University Hospital Waterford as of 18 May 2026; if she will provide the same figures as of 30 June 2023, in tabular form. [38790/26]
1122. Deputy Conor D. McGuinness asked the Minister for Health the number of WTE consultant neurologists with a special interest in migraines and headaches that are based at University Hospital Waterford in each of the years of 2024, 2025 and to date in 2026, in tabular form. [38791/26]
1123. Deputy Donna McGettigan asked the Minister for Health the reason for HSE/National Ambulance Service (NAS) apparently not giving employment to the fully qualified and PHECC registered paramedics on NRS panels whilst the NAS struggles to fill rosters and provide full ambulance cover, including in county Clare; and if she will make a statement on the matter. [38795/26]
1124. Deputy Joanna Byrne asked the Minister for Health if an urgent appointment for neurosurgery can be provided to a person living in County Louth (details supplied). [38798/26]
1125. Deputy Martin Kenny asked the Minister for Health the cost of establishing each integrated healthcare area; and the projected annual cost of operating each integrated healthcare area compared to community healthcare organisations. [38801/26]
1126. Deputy Malcolm Byrne asked the Minister for Health the mechanisms in place in her Department to ensure delivery on the commitments in the Programme for Government; the civil servant specifically responsible for overseeing such delivery; the measures that are used to assess progress; and if she will make a statement on the matter. [38815/26]
1127. Deputy Tom Brabazon asked the Minister for Health the timeline for a decision by the HSE drugs group regarding the reimbursement of risdiplam for adults living with spinal muscular atrophy. [38838/26]
1128. Deputy Ken O'Flynn asked the Minister for Health whether any HSE national policy, clinical guideline, serious incident framework, or safety protocol explicitly references signs of life following termination of pregnancy. [38839/26]
1129. Deputy Ken O'Flynn asked the Minister for Health whether any hospital is required to notify the HSE National Incident Management Team where signs of life are observed following termination of pregnancy. [38840/26]
1130. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has classified any such event as a serious reportable event, serious incident, or notifiable patient safety incident since 2019. [38841/26]
1131. Deputy Ken O'Flynn asked the Minister for Health whether her Department has sought legal advice regarding statutory reporting obligations in such cases. [38842/26]
1132. Deputy Ken O'Flynn asked the Minister for Health whether HIQA has any inspection, governance, or oversight role in relation to such incidents. [38843/26]
1133. Deputy Malcolm Byrne asked the Minister for Health if there will be an independent assessment within the HSE of the pension entitlements of a person (details supplied); and if she will make a statement on the matter. [38844/26]
1134. Deputy Ken O'Flynn asked the Minister for Health the division of the HSE or Department of Health that holds responsibility for estimating the number of patients clinically eligible for orphan medicinal products approved for reimbursement in the State (details supplied). [38846/26]
1135. Deputy Ken O'Flynn asked the Minister for Health if any budget impact assessment, cost projection, prevalence estimate, or epidemiological model was prepared in advance of reimbursement consideration for omaveloxolone (skyclarys); and the details of same. [38847/26]
1136. Deputy Ken O'Flynn asked the Minister for Health if the HSE maintains a national registry, prevalence estimate or centrally collated dataset for Friedreich's ataxia patients in the State. [38848/26]
1137. Deputy Ken O'Flynn asked the Minister for Health how reimbursement decisions for high-cost orphan medicines are financially planned where the HSE does not centrally retain data regarding the number of clinically eligible patients. [38849/26]
1138. Deputy Ken O'Flynn asked the Minister for Health if the National Centre for Pharmacoeconomics, the HSE medicines management programme, or any external body estimated the likely eligible patient cohort for omaveloxolone (skyclarys) prior to reimbursement consideration. [38850/26]
1139. Deputy Ken O'Flynn asked the Minister for Health if any hospitals, hospital groups, or specialist neurology centres currently facilitate access to omaveloxolone (skyclarys) through named-patient arrangements, manufacturer-supported supply, or exceptional approval mechanisms outside PCRS reimbursement pathways. [38854/26]
1140. Deputy Ken O'Flynn asked the Minister for Health if the HSE maintains any national policy governing interim patient access to medicines awaiting reimbursement decisions for rare diseases. [38855/26]
1141. Deputy Ken O'Flynn asked the Minister for Health if the Department or HSE has examined establishing a formal compassionate or early-access medicines framework for patients with rare progressive conditions pending health technology assistant and reimbursement determinations. [38856/26]